XM does not provide services to residents of the United States of America.
G
G

GameStop

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Stocks close with gains, led by Dow as investors look for rate insight

US STOCKS-Stocks close with gains, led by Dow as investors look for rate insight Merck up after U.S. FDA approves therapy for rare lung condition Trump's media firm extends gains after stellar debut GameStop faces 'unsustainable' sales decline, shares slide Updated at 4:11 p.m. ET/ 2011 GMT By Chuck Mikolajczak NEW YORK, March 27 (Reuters) - U.S. stocks were higher on Wednesday, with the Dow leading gains and the S&P 500 setting a closing record, paced drugmaker Merck, while investors looked tow
G
N
U
U

Dow enjoys biggest gain so far this year in light session

LIVE MARKETS-Dow enjoys biggest gain so far this year in light session All three major U.S. stock indexes end higher All 11 S&P sectors gain; Utilities lead Dollar ~flat; crude edges up; gold gains; bitcoin off >1% U.S. 10-Year Treasury yield falls to ~4.19% Welcome to the home for real-time coverage of markets brought to you by Reuters reporters.
G
G
U
U
B

Stocks gain, led by Dow as investors look for rate insight

US STOCKS-Stocks gain, led by Dow as investors look for rate insight Merck up after U.S. FDA approves therapy for rare lung condition Trump's media firm extends gains after stellar debut GameStop faces 'unsustainable' sales decline, shares slide Updated at 4:00 p.m. ET/ 2000 GMT By Chuck Mikolajczak NEW YORK, March 27 (Reuters) - U.S. stocks were higher, with the Dow leading gains on Wednesday, and the S&P 500 setting a closing record, paced by gains in drugmaker Merck, while investors looked to
G
N
U
U

Dow leads gains on Wall Street as investors await rate clues

US STOCKS-Dow leads gains on Wall Street as investors await rate clues Merck up after US FDA approves therapy for rare lung condition Trump's media firm extends gains after stellar debut GameStop faces 'unsustainable' sales decline, shares slide Indexes up: Dow 0.77%, S&P 0.46%, Nasdaq 0.22% Updated at 2:26 p.m. ET/ 1826 GMT By Chuck Mikolajczak NEW YORK, March 27 (Reuters) - The Dow was the best performing of the three major indexes on Wednesday, paced by gains in drugmaker Merck, while as inve
G
N
U
U

U.S. STOCKS Netflix, Reddit, Stoke Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Reddit, Stoke Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Dow outpaced Wall Street peers in lean trading on Wednesday, boosted by strong gains in drugmaker Merck, while investors awaited crucial economic data and commentary from the central bank's policymakers with the long holiday weekend approaching.
C
G
I
M
N
V
A
M
U
U
S
S
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.